688289.SH
圣湘生物
SSE · Healthcare · Medical - Instruments & Supplies · CN
CNY 14.90
−5.58%Margins
Gross margin
74.8%
EBITDA margin
26.6%
EBIT margin
9.6%
Net margin
9.8%
FCF margin
-10.2%
2.2%
Return on equity
1.6%
Return on assets
1.9%
Return on invested capital
0.17x
Asset turnover
CNY 216.8M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026